Cell Culture Models for Hepatitis B and D Viruses Infection: Old Challenges, New Developments and Future Strategies

被引:1
|
作者
Carpentier, Arnaud [1 ,2 ,3 ]
机构
[1] Joint Venture Hannover Med Sch MHH & Helmholtz Ctr, TWINCORE Ctr Expt & Clin Infect Res, Inst Expt Virol, Feodor Lynen Str 7, D-30625 Hannover, Germany
[2] Hannover Med Sch, Cluster Excellence RESIST EXC 2155, Hannover, Germany
[3] Hannover Med Sch, Carl Neuberg Str 1, D-30625 Hannover, Germany
来源
VIRUSES-BASEL | 2024年 / 16卷 / 05期
关键词
Hepatitis B Virus; Hepatitis D Virus; primary hepatocytes; hepatoma cell lines; HLCs; cell culture; model; ADULT HUMAN HEPATOCYTES; INNATE RESPONSE; HUMAN-LIVER; STEM-CELLS; IN-VITRO; HBV; REPLICATION; EXPRESSION; IMMUNITY; GENOME;
D O I
10.3390/v16050716
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Chronic Hepatitis B and D Virus (HBV and HDV) co-infection is responsible for the most severe form of viral Hepatitis, the Hepatitis Delta. Despite an efficient vaccine against HBV, the HBV/HDV infection remains a global health burden. Notably, no efficient curative treatment exists against any of these viruses. While physiologically distinct, HBV and HDV life cycles are closely linked. HDV is a deficient virus that relies on HBV to fulfil is viral cycle. As a result, the cellular response to HDV also influences HBV replication. In vitro studying of HBV and HDV infection and co-infection rely on various cell culture models that differ greatly in terms of biological relevance and amenability to classical virology experiments. Here, we review the various cell culture models available to scientists to decipher HBV and HDV virology and host-pathogen interactions. We discuss their relevance and how they may help address the remaining questions, with one objective in mind: the development of new therapeutic approaches allowing viral clearance in patients.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Cell-based and animal models for hepatitis B and C viruses
    Schinazi, RF
    Ilan, E
    Black, PL
    Yao, XJ
    Dagan, S
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1999, 10 (03): : 99 - 114
  • [22] Hepatocarcinogenesis by hepatitis viruses: Molecular mechanisms, experimental models and new therapeutic strategies
    Kumar, Vijay
    INDIAN JOURNAL OF VIROLOGY, 2008, 19 (01): : 66 - 66
  • [23] NEW DEVELOPMENTS IN ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS-B INFECTION
    DEMAN, RA
    HEIJTINK, RA
    NIESTERS, HGM
    SCHALM, SW
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1995, 30 : 100 - 104
  • [24] Infection of a cell culture system with hepatitis B virus.
    Ghose, R
    Sussman, NL
    Kelly, JH
    HEPATOLOGY, 2002, 36 (04) : 374A - 374A
  • [25] New developments and future challenges in prevention, diagnosis, and treatment of prosthetic joint infection
    Ricciardi, Benjamin F.
    Muthukrishnan, Gowrishankar
    Masters, Elysia A.
    Kaplan, Nathan
    Daiss, John L.
    Schwarz, Edward M.
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2020, 38 (07) : 1423 - 1435
  • [26] Challenges related to immune interventional strategies against hepatitis B virus infection
    Akbar, S. K. Md Fazle
    Yoshida, Osamu
    Hiasa, Yoichi
    Michitaka, Kojiro
    Onji, Morikazu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A61 - A61
  • [27] In vivo imaging for stem cell therapy: new developments and future challenges
    Giovanni Lucignani
    Martin Rodriguez-Porcel
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 400 - 405
  • [28] In vivo imaging for stem cell therapy: new developments and future challenges
    Lucignani, Giovanni
    Rodriguez-Porcel, Martin
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (02) : 400 - 405
  • [29] Animal models for the study of human hepatitis B and D virus infection: New insights and progress
    Burwitz, Benjamin J.
    Zhou, Zhongmin
    Li, Wenhui
    ANTIVIRAL RESEARCH, 2020, 182
  • [30] Hepatitis B virus: old, new and future approaches to antiviral treatment
    Karayiannis, P
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (04) : 761 - 785